Q2 2025 · 13F-HR
PURA VIDA INVESTMENTS, LLCholdings as filed
Filed 2025-08-13 · accession 0001590144-25-000006
$16.6M
Reported value
8
Positions
2025-06-30
Period end
The Brief · PURA VIDA INVESTMENTS, LLC · Q2 2025
AI · grounded in 13F
PURA VIDA INVESTMENTS, LLC established a new position in BBNX valued at $6.25M. The fund also initiated stakes in IMDX for $2.86M and CAI for $2.40M. Additional new positions include ESTA, OM, and NSPR. Total assets under management stand at $16.63M across 8 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 08659B102 | BBNX | BETA BIONICS INC | $6.2M | 37.6% | 2,500 | Common | SOLE |
| 68235C206 | IMDX | INSIGHT MOLECULAR DIA INC | $2.9M | 17.2% | 18,700 | Common | SOLE |
| 142152107 | CAI | CARIS LIFE SCIENCES INC | $2.4M | 14.5% | 45,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $1.9M | 11.6% | 89,940 | Common | SOLE |
| 690145206 | OM | OUTSET MED INC | $1.4M | 8.18% | 429,120 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $1.0M | 6.15% | 450,517 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $422,350 | 2.54% | 245,691 | Common | SOLE |
| 59102M104 | MGX | METAGENOMI INC | $391,299 | 2.35% | 952,134 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.